Albert David Profit & Loss Annual

BSE: 524075 | NSE: ALBERTDAVD | ISIN: INE155C01010 | Sector: Biotechnology & Drugs

847.80 +1.65 (0.20%)Updated : 15 Sep 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	333.74	349.60	322.35	305.32
Other Net	2.88	5.41	5.78	7.60
Diluted Weighted Average Shares	0.57	0.57	0.57	0.57
Gain( Loss)on Saleof Assets	0.03	0.27	0.00	0.02
Depreciation/ Amortization	9.76	6.97	6.83	8.55
Operating Income	-0.14	-3.83	40.11	36.24
Net Income	-1.49	17.20	75.42	36.17
Income Availableto Com Excl Extra Ord	-1.49	17.20	75.42	36.17
Other Operating Expenses Total	17.66	15.82	9.06	6.25
Net Income Before Taxes	0.52	25.23	97.29	50.74
Net Income After Taxes	-1.49	17.20	75.42	36.17
Income Availableto Com Incl Extra Ord	-1.49	17.20	75.42	36.17
Costof Revenue Total	131.86	133.88	145.05	143.60
Gross Profit	201.74	211.89	217.41	197.96
Interest Inc( Exp) Net- Non- Op Total	-2.24	23.38	51.39	6.87
Diluted Net Income	-1.49	17.20	75.42	36.17
DPS- Common Stock Primary Issue	5.00	5.00	11.50	9.00
Provisionfor Income Taxes	2.02	8.03	21.87	14.56
period Type	-	-	-	-
Net Income Before Extra Items	-1.49	17.20	75.42	36.17
Total Revenue	333.60	345.77	362.46	341.56
period Length	12.00	12.00	12.00	12.00
Revenue	333.60	345.77	362.46	341.56
Selling/ General/ Admin Expenses Total	172.08	190.04	158.90	145.03
Diluted Normalized EPS	-2.66	29.82	132.91	63.36
Research Development	2.37	2.89	1.95	1.90
Diluted EPS Excluding Extra Ord Items	-2.62	30.14	132.15	63.39
Unusual Expense( Income)	-	-	0.56	-